Affordability Check
How to afford Yutrepia
Generic name: treprostinil
Pick how you're covered. We'll show you the cheapest legitimate way to get Yutrepia — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About Yutrepia and its cost
What is this medication? Yutrepia is a prescription medication that contains the active ingredient treprostinil, which is a synthetic analogue of prostacyclin. It is designed as an inhalation powder administered through a specific dry powder inhaler device. This medication is primarily used to treat adults with pulmonary arterial hypertension, which is a condition where the blood pressure in the arteries of the lungs is too high. By acting as a vasodilator, the medicine helps to open up these blood vessels, making it easier for the heart to pump blood through the lungs.
In addition to its use for pulmonary arterial hypertension, Yutrepia is indicated for the treatment of pulmonary hypertension associated with interstitial lung disease. The goal of this therapy is to improve the exercise capacity of patients, allowing them to remain more active and potentially slowing the progression of their symptoms. By reducing the resistance in the pulmonary vascular bed, the medication helps alleviate the strain on the heart and improves overall respiratory efficiency for individuals suffering from these specific types of lung-related cardiovascular issues.
Yutrepia is made by Liquidia. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford Yutrepia?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for Yutrepia?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Liquidia has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover Yutrepia?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Hypertension?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about Yutrepia
Full Yutrepia drug page
FDA label, prior authorization rules, full indications list
More options for Hypertension
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3